Home/BioLineRx/Philip A. Serlin
PA

Philip A. Serlin

Chief Executive Officer

BioLineRx

Therapeutic Areas

BioLineRx Pipeline

DrugIndicationPhase
GLIX1Glioblastoma, Other Solid TumorsPhase 1
MotixafortideMetastatic Pancreatic Cancer (1st line)Phase 2b